|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Minerva Neurosciences, Inc. (NERV) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
42,721,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of product candidates to treat patients suffering from central nervous system diseases. Co.'s primary product candidate is roluperidone, a compound it is developing for the treatment of negative symptoms in patients with schizophrenia. Co. holds the license to roluperidone from Mitsubishi Tanabe Pharma Corporation with the rights to develop, sell and import roluperidone globally, excluding most of Asia. Co. also has exclusive rights to develop and commercialize MIN-301, a compound for the treatment of Parkinson's disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
53,056 |
Total Sell Value |
$0 |
$0 |
$0 |
$206,193 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
4 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Boehringer Ag |
10% Owner |
|
2023-06-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,275,000 |
|
- |
|
Luthringer Remy |
CEO |
|
2023-05-02 |
4 |
S |
$3.76 |
$13,690 |
D/D |
(3,641) |
68,994 |
|
- |
|
Luthringer Remy |
CEO |
|
2023-05-01 |
4 |
S |
$3.85 |
$91,449 |
D/D |
(23,753) |
72,635 |
|
- |
|
Ahlholm Frederick W |
SVP, CFO and Secretary |
|
2023-05-01 |
4 |
S |
$4.48 |
$16,038 |
D/D |
(3,580) |
17,518 |
|
- |
|
Race Geoff |
President |
|
2023-05-01 |
4 |
S |
$3.85 |
$85,016 |
D/D |
(22,082) |
51,324 |
|
- |
|
Luthringer Remy |
CEO |
|
2023-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
88,077 |
96,388 |
|
- |
|
Ahlholm Frederick W |
SVP, CFO and Secretary |
|
2023-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
19,843 |
21,098 |
|
- |
|
Race Geoff |
President |
|
2023-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
46,987 |
73,406 |
|
- |
|
Barclays Plc |
10% Owner |
|
2022-08-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
605,230 |
|
- |
|
Kupfer David |
Director |
|
2021-12-01 |
4 |
S |
$0.88 |
$48,959 |
D/D |
(55,635) |
163,553 |
|
- |
|
Ahlholm Frederick W |
SVP, Chief Accounting Officer |
|
2020-12-16 |
4 |
S |
$2.64 |
$4,871 |
D/D |
(1,845) |
10,039 |
|
- |
|
Reilly Joseph H. |
SVP & Chief Operating Officer |
|
2020-12-16 |
4 |
S |
$2.64 |
$8,522 |
D/D |
(3,228) |
31,747 |
|
- |
|
Race Geoff |
EVP, CFO & CBO |
|
2020-12-16 |
4 |
S |
$2.64 |
$16,342 |
D/D |
(6,190) |
211,354 |
|
- |
|
Luthringer Remy |
CEO |
|
2020-12-16 |
4 |
S |
$2.64 |
$3,432 |
D/D |
(1,300) |
66,490 |
|
- |
|
Ahlholm Frederick W |
SVP, Chief Accounting Officer |
|
2020-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
11,884 |
|
- |
|
Reilly Joseph H. |
SVP & Chief Operating Officer |
|
2020-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
34,975 |
|
- |
|
Race Geoff |
EVP, CFO & CBO |
|
2020-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
217,544 |
|
- |
|
Luthringer Remy |
CEO |
|
2020-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
67,790 |
|
- |
|
Van Heek G Jan |
Director |
|
2020-09-10 |
4 |
B |
$2.97 |
$20,790 |
D/D |
7,000 |
20,333 |
2.39 |
- |
|
Ahlholm Frederick W |
SVP, Chief Accounting Officer |
|
2020-05-26 |
4 |
AS |
$15.00 |
$125,085 |
D/D |
(8,339) |
6,884 |
|
- |
|
Ahlholm Frederick W |
SVP, Chief Accounting Officer |
|
2019-12-17 |
4 |
S |
$7.10 |
$11,055 |
D/D |
(1,557) |
15,223 |
|
- |
|
Reilly Joseph H. |
SVP & Chief Operating Officer |
|
2019-12-17 |
4 |
S |
$7.10 |
$19,340 |
D/D |
(2,724) |
26,225 |
|
- |
|
Luthringer Remy |
CEO |
|
2019-12-17 |
4 |
S |
$7.10 |
$17,125 |
D/D |
(2,412) |
49,040 |
|
- |
|
Race Geoff |
EVP, CFO & CBO |
|
2019-12-17 |
4 |
S |
$7.10 |
$41,365 |
D/D |
(5,826) |
205,044 |
|
- |
|
Ahlholm Frederick W |
SVP, Chief Accounting Officer |
|
2019-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
16,780 |
|
- |
|
144 Records found
|
|
Page 1 of 6 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|